Unleashing the tiger - iatrogenic autoimmunity from cancer immunotherapy drugs

JRSM Open. 2018 Jan 8;9(1):2054270417746905. doi: 10.1177/2054270417746905. eCollection 2018 Jan.

Abstract

Immune checkpoint inhibitors can lead to the development of organ and non-organ specific immune related adverse events.

Keywords: drugs; endocrinology; musculoskeletal and joint diseases; oncology; pharmacology and therapeutics; rheumatology; unwanted effects/adverse reactions.

Publication types

  • Case Reports